Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (2R,3S) 3 Phenylisoserine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN113636956A details a high-yield, metal-free synthesis of docetaxel chiral intermediates, offering significant cost and supply chain advantages for API manufacturers.
Patent CN111763179A details a novel oxazolidine-based route for paclitaxel side chains, offering high purity, safety, and cost reduction in API manufacturing.